(2S)-N-[(3S,4S)-5-(4-acetylbenzoyl)-1-[(3-cyclopropylquinolin-4-yl)methyl]-4-methyl-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide

C36H37N5O4 — CID 90082434

IUPAC(2S)-N-[(3S,4S)-5-(4-acetylbenzoyl)-1-[(3-cyclopropylquinolin-4-yl)methyl]-4-methyl-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide
SMILESCN[C@@H](C)C(=O)N[C@@H]1C(=O)N(Cc2c(C3CC3)cnc3ccccc23)c2ccccc2N(C(=O)c2ccc(C(C)=O)cc2)[C@H]1C
InChIInChI=1S/C36H37N5O4/c1-21(37-4)34(43)39-33-22(2)41(35(44)26-17-13-24(14-18-26)23(3)42)32-12-8-7-11-31(32)40(36(33)45)20-29-27-9-5-6-10-30(27)38-19-28(29)25-15-16-25/h5-14,17-19,21-22,25,33,37H,15-16,20H2,1-4H3,(H,39,43)/t21-,22-,33-/m0/s1
InChIKeyFSSFEVHWWBPTSY-RACYCIBVSA-N
MW603.72 g/mol
LogP4.99
Rot. Bonds8

About (2S)-N-[(3S,4S)-5-(4-acetylbenzoyl)-1-[(3-cyclopropylquinolin-4-yl)methyl]-4-methyl-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide

(2S)-N-[(3S,4S)-5-(4-acetylbenzoyl)-1-[(3-cyclopropylquinolin-4-yl)methyl]-4-methyl-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide (PubChem CID 90082434) has the molecular formula C36H37N5O4 and a molecular weight of 603.72 g/mol. Its IUPAC name is (2S)-N-[(3S,4S)-5-(4-acetylbenzoyl)-1-[(3-cyclopropylquinolin-4-yl)methyl]-4-methyl-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide.

Molecular Properties

Compound Name(2S)-N-[(3S,4S)-5-(4-acetylbenzoyl)-1-[(3-cyclopropylquinolin-4-yl)methyl]-4-methyl-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide
PubChem CID90082434
Molecular FormulaC36H37N5O4
Molecular Weight603.72 g/mol
Exact Mass603.28
IUPAC Name(2S)-N-[(3S,4S)-5-(4-acetylbenzoyl)-1-[(3-cyclopropylquinolin-4-yl)methyl]-4-methyl-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide
SMILESCN[C@@H](C)C(=O)N[C@@H]1C(=O)N(Cc2c(C3CC3)cnc3ccccc23)c2ccccc2N(C(=O)c2ccc(C(C)=O)cc2)[C@H]1C
InChIInChI=1S/C36H37N5O4/c1-21(37-4)34(43)39-33-22(2)41(35(44)26-17-13-24(14-18-26)23(3)42)32-12-8-7-11-31(32)40(36(33)45)20-29-27-9-5-6-10-30(27)38-19-28(29)25-15-16-25/h5-14,17-19,21-22,25,33,37H,15-16,20H2,1-4H3,(H,39,43)/t21-,22-,33-/m0/s1
InChIKeyFSSFEVHWWBPTSY-RACYCIBVSA-N
XLogP4.99
TPSA111.71 Ų
H-Bond Donors2
H-Bond Acceptors6
Rotatable Bonds8
Heavy Atoms45
Complexity—

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500603.72
LogP ≤ 54.99
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 106

Analyze (2S)-N-[(3S,4S)-5-(4-acetylbenzoyl)-1-[(3-cyclopropylquinolin-4-yl)methyl]-4-methyl-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (2S)-N-[(3S,4S)-5-(4-acetylbenzoyl)-1-[(3-cyclopropylquinolin-4-yl)methyl]-4-methyl-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide?
The IUPAC name of (2S)-N-[(3S,4S)-5-(4-acetylbenzoyl)-1-[(3-cyclopropylquinolin-4-yl)methyl]-4-methyl-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide (CID 90082434) is (2S)-N-[(3S,4S)-5-(4-acetylbenzoyl)-1-[(3-cyclopropylquinolin-4-yl)methyl]-4-methyl-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide.
What is the SMILES notation for (2S)-N-[(3S,4S)-5-(4-acetylbenzoyl)-1-[(3-cyclopropylquinolin-4-yl)methyl]-4-methyl-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide?
The canonical SMILES for (2S)-N-[(3S,4S)-5-(4-acetylbenzoyl)-1-[(3-cyclopropylquinolin-4-yl)methyl]-4-methyl-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide is CN[C@@H](C)C(=O)N[C@@H]1C(=O)N(Cc2c(C3CC3)cnc3ccccc23)c2ccccc2N(C(=O)c2ccc(C(C)=O)cc2)[C@H]1C.
What is the InChIKey of (2S)-N-[(3S,4S)-5-(4-acetylbenzoyl)-1-[(3-cyclopropylquinolin-4-yl)methyl]-4-methyl-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide?
The InChIKey is FSSFEVHWWBPTSY-RACYCIBVSA-N. The full InChI is InChI=1S/C36H37N5O4/c1-21(37-4)34(43)39-33-22(2)41(35(44)26-17-13-24(14-18-26)23(3)42)32-12-8-7-11-31(32)40(36(33)45)20-29-27-9-5-6-10-30(27)38-19-28(29)25-15-16-25/h5-14,17-19,21-22,25,33,37H,15-16,20H2,1-4H3,(H,39,43)/t21-,22-,33-/m0/s1.
What are the key properties of (2S)-N-[(3S,4S)-5-(4-acetylbenzoyl)-1-[(3-cyclopropylquinolin-4-yl)methyl]-4-methyl-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide?
(2S)-N-[(3S,4S)-5-(4-acetylbenzoyl)-1-[(3-cyclopropylquinolin-4-yl)methyl]-4-methyl-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide has a molecular weight of 603.72 g/mol, XLogP of 4.99, 8 rotatable bonds, 2 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for (2S)-N-[(3S,4S)-5-(4-acetylbenzoyl)-1-[(3-cyclopropylquinolin-4-yl)methyl]-4-methyl-2-oxo-3,4-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide is sourced from PubChem (CID 90082434), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).